Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Gail Hecht MD
Gail Hecht MD Editor-in-Chief
Scott Cotler MD
Scott J. Cotler MD Associate Editor
Steven Edmundowicz MD, MASGE
Steven A. Edmundowicz MD, MASGE Associate Editor
See All Experts
featured
Published in Gastroenterology

Journal Scan / Research · July 30, 2019

Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases

Clinical Gastroenterology and Hepatology

 

 Save  Recommend
 Share

Additional Info

Clinical Gastroenterology and Hepatology
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases
Clin. Gastroenterol. Hepatol. 2019 Jul 11;[EPub Ahead of Print], JE Axelrad, A Bazarbashi, J Zhou, D Castañeda, A Gujral, D Sperling, J Glass, M Agrawal, S Hong, G Lawlor, D Hudesman, S Chang, S Shah, V Yajnik, A Ananthakrishnan, H Khalili, JF Colombel, S Itzkowitz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated